After weekly injections of the anti-TIGIT mAb, HBs-tg mice developed chronic hepatitis, as evidenced by gradually increased ALT levels that were significantly higher than those in rat IgG-treated HBs-tg mice (Fig. 1b). The gene discussed is TIGIT; the disease is chronic hepatitis.